HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing…
HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today anno… [4296 chars]
Source: GlobeNewswire | Published: 2026-01-21T21:15:00Z
Credit: GlobeNewswire
